Streetbeat News

Earnings

MSFT

NVDA

The stock market has experienced a significant bull run, with Microsoft (MSFT) reaching all-time highs. Despite various economic data releases, bearish investors have not gained an advantage. The upcoming Nvidia (NVDA) earnings report is seen as a potential catalyst for a market pullback, especially given NVDA's importance in the recent market rally and its complications with federal restrictions on sales to China. Analysts expect a positive earnings report from NVDA, but if they are incorrect, it could lead to the pullback bears are hoping for.

Portfolio Pulse from Thrash Capital

November 17, 2023 | 2:30 pm

VALE

Vale Inc. (NYSE:VALE) stock is currently trading at $15.19, with a slight decrease of 0.07% in the current session. Despite this, the stock has seen a significant increase of 22.40% over the past month and a 1.00% increase over the past year. The article discusses Vale's P/E ratio in comparison to the Metals & Mining industry average. Vale's P/E is lower than the industry average, which could indicate that the stock is undervalued or that shareholders have low expectations for future performance.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:30 pm

BJ

BJ's Wholesale Club Holdings Inc (NYSE:BJ) reported Q3 FY23 sales of $4.92 billion, missing estimates by $0.04 billion. Comparable club sales were up 0.3%, with flat sales excluding gasoline. Membership fee income rose 6.6%, and digitally enabled sales increased 16% Y/Y. Gross profit and operating income saw modest increases, while adjusted EPS of $0.98 beat estimates by $0.02. The company repurchased $17.1 million in stock and reaffirmed its FY23 EPS guidance, but lowered its comparable club sales growth forecast. BJ's stock fell 4.59% in premarket trading.

Portfolio Pulse from Akanksha Bakshi

November 17, 2023 | 2:04 pm

BLRX

BioLine Rx (NASDAQ:BLRX) is scheduled to release its quarterly earnings report on Monday, 2023-11-20, with analysts expecting an EPS of $-0.21. Investors are looking for an earnings beat and positive guidance for the next quarter. BioLine Rx's stock performance has been strong over the last 52 weeks, with shares up 180.25%, trading at $1.86 as of November 16. Past earnings performance has shown varied impacts on stock price.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:02 pm

ENTA

Enanta Pharma (NASDAQ:ENTA) is scheduled to release its quarterly earnings report on Monday, 2023-11-20, with an estimated EPS of $-2.00. Investors are looking for a beat on this estimate and positive guidance for future growth. Historically, Enanta has experienced share price drops following earnings reports, even when beating EPS estimates. Over the past year, ENTA shares have declined by 81.27%, indicating potential concern among long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:01 pm

SYM

Symbotic (NASDAQ:SYM) is scheduled to release its quarterly earnings report on Monday, 2023-11-20, with analysts expecting an EPS of $-0.12. Investors are looking for an earnings beat and positive guidance for the next quarter. Symbotic's stock performance has been strong over the last year, with shares up 269.14%. However, past earnings misses have led to significant share price drops the following day.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:01 pm

ZEPP

Zepp Health (NYSE:ZEPP) is scheduled to release its quarterly earnings report on Monday, 2023-11-20, with analysts expecting an EPS of $0.03. Investors are looking for an earnings beat and positive guidance for future growth. Zepp Health's stock performance has been negative over the last 52 weeks, with shares down 6.25%. The company's past earnings have resulted in mixed share price changes on the following day, with the last quarter showing no change despite an EPS miss of $0.14.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:01 pm

KEYS

Keysight Technologies (NYSE:KEYS) is scheduled to release its quarterly earnings report on Monday, 2023-11-20. Analysts predict an EPS of $1.87. Investors are looking for an earnings beat and positive guidance for future growth. In the past, KEYS's stock price has shown volatility post-earnings, with a 13.78% drop after last quarter's beat. Shares are currently trading at $132.8, down 22.85% over the last year. The upcoming earnings report could be a significant event for shareholders.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:01 pm

RNW

ReNew Energy Glb (NASDAQ:RNW) is scheduled to release its quarterly earnings report on Monday, 2023-11-20. Analysts predict an EPS of $0.10. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, RNW's stock price has shown varied reactions to past earnings results. The stock is currently trading at $5.9, with a 52-week decrease of 0.17%. The upcoming earnings report could influence the stock's performance, especially if the actual results differ from expectations.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:01 pm

BRBR

BellRing Brands (NYSE:BRBR) is expected to release its quarterly earnings report on Monday, 2023-11-20, with analysts estimating an EPS of $0.39. Investors are looking for an earnings beat and positive guidance for future growth. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, BRBR beat the EPS estimate by $0.02, leading to a 2.85% stock price increase the following day. Over the last year, BRBR shares have risen by 94.84%, indicating a positive trend for long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 2:00 pm